Choose Language
Select a language for news translation.
Written by Rick Orford for The Motley Fool -> AST SpaceMobile (NASDAQ: ASTS) and Rocket Lab (NASDAQ: RKLB) are pursuing radically different strategies within …
Written by Dave Kovaleski for The Motley Fool -> Billionaire investor Stanley Druckenmiller has a long track record of success. His Duquesne Family office on…
Berkshire Hathaway's cash reserves dropped by $30 billion in Q1 2024 under new CEO Greg Abel, marking the largest quarterly decline in its history as the firm …
Written by Johnny Rice for The Motley Fool -> SpaceX (SPCX) stock surged Friday after a major post-IPO lockup expiration failed to trigger the sell-off invest…
Recently, Google Photos users have noticed that the app won’t let them search for terms related to regulated or illicit substances . While that appears to be a…
Pink is becoming a dominant color in 2026 due to its association with sustainability, approachability, and gender neutrality, with brands from fashion to tech …
Nebius is valued at $48.6 billion—55x its reported revenue—but its annualized run rate is $1.9 billion, implying a more reasonable 15x multiple if targets are …
Written by Rick Orford for The Motley Fool -> Palantir (NASDAQ: PLTR) is pairing its mission-critical software with advanced AI hardware from Nvidia (NASDAQ: …
Written by Reuben Gregg Brewer for The Motley Fool -> Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical devi…
SPDR Biotech ETF offers higher risk/reward with a 0.35% fee and 1.45 beta, while iShares Global Healthcare ETF provides stability and 1.4% yield at 0.46% fee a…
Written by Brendan Coffey for The Motley Fool -> iShares Global Healthcare ETF offers a 1.4% dividend yield and lower price volatility than State Street SPDR …
